Stock News

New Senior Investment Group Inc. (SNR) Analysts See $0.28 EPS; Illumina Has 1.1 Sentiment

Analysts expect New Senior Investment Group Inc. (NYSE:SNR) to report $0.28 EPS on February, 27.They anticipate $0.03 EPS change or 9.68% from last quarter’s $0.31 EPS. SNR’s profit would be $23.00 million giving it 6.26 P/E if the $0.28 EPS is correct. After having $0.28 EPS previously, New Senior Investment Group Inc.’s analysts see 0.00% EPS growth. The stock increased 0.86% or $0.06 during the last trading session, reaching $7.01. About 711,720 shares traded or 4.94% up from the average. New Senior Investment Group Inc. (NYSE:SNR) has declined 7.36% since February 16, 2017 and is downtrending. It has underperformed by 24.06% the S&P500.

Illumina, Inc. provides sequencing and array solutions for genetic analysis. The company has market cap of $33.68 billion. The companyÂ’s sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It has a 46.57 P/E ratio. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array.

Bender Robert & Associates holds 6.35% of its portfolio in Illumina, Inc. for 55,474 shares. Wellington Shields & Co. Llc owns 88,319 shares or 5.81% of their US portfolio. Moreover, Edgewood Management Llc has 4.7% invested in the company for 5.13 million shares. The United Kingdom-based Baillie Gifford & Co has invested 4.61% in the stock. Rosenblum Silverman Sutton S F Inc Ca, a California-based fund reported 49,269 shares.

Ratings analysis reveals 22% of Illumina’s analysts are positive. Out of 9 Wall Street analysts rating Illumina, 2 give it “Buy”, 2 “Sell” rating, while 5 recommend “Hold”. The lowest target is $100.0 while the high is $185.0. The stock’s average target of $142 is -38.03% below today’s ($229.13) share price. ILMN was included in 9 notes of analysts from August 22, 2016. Cantor Fitzgerald maintained Illumina, Inc. (NASDAQ:ILMN) on Tuesday, October 11 with “Hold” rating. The firm has “Underweight” rating given on Wednesday, December 7 by Morgan Stanley. UBS maintained the shares of ILMN in report on Wednesday, February 1 with “Buy” rating. Canaccord Genuity maintained Illumina, Inc. (NASDAQ:ILMN) rating on Tuesday, October 11. Canaccord Genuity has “Hold” rating and $136.0 target. The firm has “Buy” rating given on Tuesday, January 10 by Bank of America. Deutsche Bank initiated Illumina, Inc. (NASDAQ:ILMN) rating on Wednesday, January 18. Deutsche Bank has “Hold” rating and $160.0 target. The firm has “Neutral” rating given on Tuesday, October 11 by Citigroup. The company was downgraded on Monday, August 22 by CL King. First Analysis downgraded it to “Underweight” rating and $116.0 target in Wednesday, November 2 report.

The stock increased 2.70% or $6.02 during the last trading session, reaching $229.13. About 804,863 shares traded. Illumina, Inc. (ILMN) has risen 28.24% since February 16, 2017 and is uptrending. It has outperformed by 11.54% the S&P500.

Since January 1, 0001, it had 0 insider purchases, and 20 insider sales for $39.38 million activity.

Among 5 analysts covering New Senior Investment (NYSE:SNR), 1 have Buy rating, 2 Sell and 2 Hold. Therefore 20% are positive. New Senior Investment had 9 analyst reports since August 7, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Thursday, September 10 by Stifel Nicolaus. The firm has “Buy” rating given on Friday, August 7 by Compass Point. Morgan Stanley maintained it with “Underweight” rating and $8 target in Thursday, December 14 report. The stock has “Underperform” rating by Bank of America on Tuesday, September 15. On Friday, April 29 the stock rating was maintained by Compass Point with “Buy”. As per Thursday, August 31, the company rating was downgraded by Compass Point. Stifel Nicolaus maintained New Senior Investment Group Inc. (NYSE:SNR) on Friday, November 3 with “Hold” rating. Canaccord Genuity maintained it with “Buy” rating and $15 target in Friday, November 13 report.

New Senior Investment Group is a publicly-traded real estate investment trust with a diversified portfolio of senior housing properties located across the United States. The company has market cap of $575.86 million. As of September 30, 2017, New Senior is one of the largest owners of senior housing properties, with 148 properties across 37 states. It currently has negative earnings. New Senior is managed by an affiliate of Fortress Investment Group LLC, a global investment management firm.

Leave a Reply

Your email address will not be published. Required fields are marked *